| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $419.5M | +1.9% | +24.7% |
| R&D Expense | $80.4M | +3.8% | +17.5% |
| SG&A Expense | $56.0M | -6.1% | +9.9% |
| Operating Income | $11.8M | -19.6% | +3100.3% |
| Pre-tax Income | $12.4M | +53.1% | +229.8% |
| Income Tax | $3.6M | +127.8% | +94.3% |
| Net Income | $8.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $476.9M | -7.6% | +47.0% |
| Current Assets | $1.08B | +4.3% | +25.6% |
| Total Assets | $1.21B | +4.1% | +25.1% |
| Current Liabilities | $376.1M | +3.4% | +16.0% |
| Total Liabilities | $416.5M | +3.8% | +22.6% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $175.5M | — | — |
| Capital Expenditures | $23.1M | — | — |
| Investing Cash Flow | -$51.6M | — | — |
| Financing Cash Flow | -$23.7M | — | — |
| Free Cash Flow | $152.4M | — | — |
| +35.1% |
| +360.6% |
| EPS (Basic) | $0.04 | +33.3% | +300.0% |
| EPS (Diluted) | $0.04 | +33.3% | +300.0% |
| $797.2M |
| +4.2% |
| +26.4% |